The DOI matches its Crossref record; 175 of the 175 references it cites were found in a registry or an index.
Chitosan-based nanostructures: A delivery platform for ocular therapeutics
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cyclodextrins and their uses: a review
Del Valle, E. M. M. (2004) · Process Biochemistry · doi:10.1016/s0032-9592(03)00258-9 · Cited by 3,375
Chitosan as antimicrobial agent: applications and mode of action.
Rabea, E. I., Badawy, M. E.-T., Stevens, C. V., Smagghe, G., & Steurbaut, W. (2003) · Biomacromolecules · doi:10.1021/bm034130m · Cited by 3,123
On the mechanisms of biocompatibility
Williams, D. F. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.04.023 · Cited by 2,772
Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency
Mao, H.-Q., Roy, K., Troung-Le, V. L., Janes, K. A., Lin, K. Y., Wang, Y., August, J. T., & Leong, K. W. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00361-8 · Cited by 1,228
In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers
Lehr, C.-M., Bouwstra, J. A., Schacht, E. H., & Junginger, H. E. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90353-4 · Cited by 1,035
Challenges and obstacles of ocular pharmacokinetics and drug delivery
Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.027 · Cited by 1,003
The use of mucoadhesive polymers in ocular drug delivery
LUDWIG, A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.005 · Cited by 922
Gan, Q., Wang, T., Cochrane, C., & McCarron, P. (2005) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2005.06.001 · Cited by 908
Polysaccharide colloidal particles as delivery systems for macromolecules
Janes, K. A., Calvo, P., & Alonso, M. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00123-x · Cited by 900
Self-citationIn vitro and in vivo degradation of films of chitin and its deacetylated derivatives
Tomihata, K., & Ikada, Y. (1997) · Biomaterials · doi:10.1016/s0142-9612(96)00167-6 · Cited by 821
Calvo, P., Remuñan-López, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Pharmaceutical Research · doi:10.1023/a:1012128907225 · Cited by 817
Self-citationSogias, I. A., Williams, A. C., & Khutoryanskiy, V. V. (2008) · Biomacromolecules · doi:10.1021/bm800276d · Cited by 779
Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
Artursson, P., Lindmark, T., Davis, S. S., & Illum, L. (1994) · Pharmaceutical Research · doi:10.1023/a:1018967116988 · Cited by 765
Hyaluronan: Preparation, Structure, Properties, and Applications
Lapčík, L., Lapčík, L., De Smedt, S., Demeester, J., & Chabreček, P. (1998) · Chemical Reviews · doi:10.1021/cr941199z · Cited by 737
Ophthalmic drug delivery systems—Recent advances
Le Bourlais, C., Acar, L., Zia, H., Sado, P. A., Needham, T., & Leverge, R. (1998) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(97)00002-5 · Cited by 698
Cyclodextrins: Their Future in Drug Formulation and Delivery
Stella, V. J., & Rajewski, R. A. (1997) · Pharmaceutical Research · doi:10.1023/a:1012136608249 · Cited by 697
De Campos, A. M., Sánchez, A., & Alonso, M. J. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00760-8 · Cited by 666
Self-citationDevelopment and characterisation of chitosan nanoparticles for siRNA delivery
Katas, H., & Alpar, H. O. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.07.021 · Cited by 642
Recent Perspectives in Ocular Drug Delivery
Gaudana, R., Jwala, J., Boddu, S. H. S., & Mitra, A. K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9694-0 · Cited by 605
Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery
MacLaughlin, F. C., Mumper, R. J., Wang, J., Tagliaferri, J. M., Gill, I., Hinchcliffe, M., & Rolland, A. P. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00097-2 · Cited by 601
Chitosans as Absorption Enhancers for Poorly Absorbable Drugs 2: Mechanism of Absorption Enhancement
Schipper, N. G. M., Olsson, S., Hoogstraate, J. A., deBoer, A. G., Vårum, K. M., & Artursson, P. (1997) · Pharmaceutical Research · doi:10.1023/a:1012160102740 · Cited by 586
RNA Interference in Vitro and in Vivo Using a Novel Chitosan/siRNA Nanoparticle System
Howard, K. A., Rahbek, U. L., Liu, X., Damgaard, C. K., Glud, S. Z., Andersen, M. Ø., Hovgaard, M. B., Schmitz, A., Nyengaard, J. R., Besenbacher, F., et al. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.04.010 · Cited by 585
Effect of chitosan on epithelial permeability and structure
Dodane, V (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00030-7 · Cited by 578
MOTWANI, S., CHOPRA, S., TALEGAONKAR, S., KOHLI, K., AHMAD, F., & KHAR, R. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.09.009 · Cited by 557
Erbacher, P., Zou, S., Bettinger, T., Steffan, A.-M., & Remy, J.-S. (1998) · Pharmaceutical Research · doi:10.1023/a:1011981000671 · Cited by 536
Borchard, G. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00198-3 · Cited by 534
Köping-Höggård, M., Tubulekas, I., Guan, H., Edwards, K., Nilsson, M., Vårum, K., & Artursson, P. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301492 · Cited by 532
Richardson, S. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00378-0 · Cited by 532
Structure, biochemistry, and assembly of epithelial tight junctions
Gumbiner, B. (1987) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1987.253.6.c749 · Cited by 531
Human enzymatic activities related to the therapeutic administration of chitin derivatives
Muzzarelli, R. A. A. (1997) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000584 · Cited by 516
Nanotechnology in ocular drug delivery
Sahoo, S. K., Dilnawaz, F., & Krishnakumar, S. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.021 · Cited by 510
Key issues in non-viral gene delivery
Pouton, C. W., & Seymour, L. W. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00048-9 · Cited by 440
A Simple Rheological Method for the in Vitro Assessment of Mucin-Polymer Bioadhesive Bond Strength
Hassan, E. E., & Gallo, J. M. (1990) · Pharmaceutical Research · doi:10.1023/a:1015812615635 · Cited by 438
Sato, T., Ishii, T., & Okahata, Y. (2001) · Biomaterials · doi:10.1016/s0142-9612(00)00385-9 · Cited by 426
Current and future ophthalmic drug delivery systems
del Amo, E. M., & Urtti, A. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2007.11.002 · Cited by 414
High throughput solubility measurement in drug discovery and development
Alsenz, J., & Kansy, M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.007 · Cited by 412
de Campos, A. M., Diebold, Y., Carvalho, E. L. S., Sánchez, A., & José Alonso, M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000026432.75781.cb · Cited by 404
Topical and systemic drug delivery to the posterior segments
HUGHES, P., OLEJNIK, O., CHANGLIN, J., & WILSON, C. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.004 · Cited by 400
The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing
Liu, X., Howard, K. A., Dong, M., Andersen, M. Ø., Rahbek, U. L., Johnsen, M. G., Hansen, O. C., Besenbacher, F., & Kjems, J. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.11.004 · Cited by 391
Köping-Höggård, M., Vårum, K., Issa, M., Danielsen, S., Christensen, B., Stokke, B., & Artursson, P. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302312 · Cited by 385
Nanotechnology in Ocular Drug Delivery
Patel, D., Pathak, D., & Giradkar, P. (2021) · Nanocarriers: Drug Delivery System · doi:10.1007/978-981-33-4497-6_18 · Cited by 362
Felt, O. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00003-4 · Cited by 358
Ocular absorption following topical delivery
Järvinen, K., Järvinen, T., & Urtti, A. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00010-5 · Cited by 358
Bourges, J.-L., Gautier, S. E., Delie, F., Bejjani, R. A., Jeanny, J.-C., Gurny, R., BenEzra, D., & Behar-Cohen, F. F. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1068 · Cited by 357
Ocular drug delivery conventional ocular formulations
Lang, J. C. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00012-v · Cited by 356
The potential of chitosan in ocular drug delivery
Alonso, M. J., & Sánchez, A. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022476 · Cited by 352
Self-citationThe Impact of Nanobiotechnology on the Development of New Drug Delivery Systems
Kayser, O., Lemke, A., & Hernandez-Trejo, N. (2005) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201053167158 · Cited by 349
Mannermaa, E., Vellonen, K.-S., & Urtti, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.024 · Cited by 349
Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers
Calvo, P., Vila-Jato, J. L., & Alonso, M. J. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)00083-5 · Cited by 347
Self-citationMicroemulsions as ocular drug delivery systems: recent developments and future challenges
Vandamme, T. F. (2002) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00017-9 · Cited by 345
Microspheres and nanoparticles used in ocular delivery systems
Zimmer, A., & Kreuter, J. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00017-2 · Cited by 336
Eliaz, R. E., & Szoka, F. C. (2001) · PubMed · Cited by 330
Ghate, D., & Edelhauser, H. F. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.2.275 · Cited by 329
Mechanism of cell transfection with plasmid/chitosan complexes
Ishii, T., Okahata, Y., & Sato, T. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00362-5 · Cited by 323
In vitro degradation rates of partially N-acetylated chitosans in human serum
Vårum, K. M., Myhr, M. M., Hjerde, R. J. N., & Smidsrød, O. (1997) · Carbohydrate Research · doi:10.1016/s0008-6215(96)00332-1 · Cited by 322
Ocular novel drug delivery: impacts of membranes and barriers
Barar, J., Javadzadeh, A. R., & Omidi, Y. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.5.567 · Cited by 308
Csaba, N., Köping-Höggård, M., & Alonso, M. J. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.07.028 · Cited by 307
Self-citationCyclodextrins in ophthalmic drug delivery
Loftssona, T. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00055-6 · Cited by 305
Penetration Enhancers and Ocular Bioadhesives: Two New Avenues for Ophthalmic Drug Delivery
Kaur, I. P., & Smitha, R. (2002) · Drug Development and Industrial Pharmacy · doi:10.1081/ddc-120002997 · Cited by 305
Calvo, P., Vila-Jato, J. L., & Alonso, M. J. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950474+ · Cited by 302
Self-citationCell culture models of the ocular barriers
Hornof, M., Toropainen, E., & Urtti, A. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.01.009 · Cited by 300
Cao, Y., Zhang, C., Shen, W., Cheng, Z., Yu, L. (., & Ping, Q. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.009 · Cited by 299
Lysozyme degradation of partially deacetylated chitin, its films and hydrogels
Pangburn, S. H., Trescony, P. V., & Heller, J. (1982) · Biomaterials · doi:10.1016/0142-9612(82)90043-6 · Cited by 298
Development of non-viral vectors for systemic gene delivery
Liu, F., & Huang, L. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00494-1 · Cited by 294
Ophthalmic drug delivery systems
Shell, J. W. (1984) · Survey of Ophthalmology · doi:10.1016/0039-6257(84)90168-1 · Cited by 291
Pouton, C. W., & Seymour, L. W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00133-2 · Cited by 291
Chemistry and Biology of Hyaluronan
(2004) · Elsevier eBooks · doi:10.1016/b978-0-08-044382-9.x5030-4 · Cited by 288
Novel Hyaluronic Acid-Chitosan Nanoparticles for Ocular Gene Therapy
de la Fuente, M., Seijo, B., & Alonso, M. J. (2008) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.07-1077 · Cited by 287
Self-citationde Salamanca, A. E., Diebold, Y., Calonge, M., Garci´a-Vazquez, C., Callejo, S., Vila, A., & Alonso, M. J. (2006) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0495 · Cited by 286
Self-citationStudy of an alginate/HPMC-based in situ gelling ophthalmic delivery system for gatifloxacin
Liu, Z., Li, J., Nie, S., Liu, H., Ding, P., & Pan, W. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.01.029 · Cited by 276
Ocular drug delivery by liposome–chitosan nanoparticle complexes (LCS-NP)
Diebold, Y., Jarrín, M., Sáez, V., Carvalho, E. L. S., Orea, M., Calonge, M., Seijo, B., & Alonso, M. J. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.11.028 · Cited by 273
Self-citationCharacterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera.
Hämäläinen, K. M., Kananen, K., Auriola, S. O. K., Kontturi, K., & Urtti, A. O. (1997) · PubMed · Cited by 266
van der Merwe, S. M., Verhoef, J. C., Verheijden, J. H. M., Kotzé, A. F., & Junginger, H. E. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.023 · Cited by 260
Oral Bioavailability of Insulin Contained in Polysaccharide Nanoparticles
Sarmento, B., Ribeiro, A., Veiga, F., Ferreira, D., & Neufeld, R. (2007) · Biomacromolecules · doi:10.1021/bm0703923 · Cited by 260
Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro
Gomes, J. A. P. (2004) · British Journal of Ophthalmology · doi:10.1136/bjo.2003.027573 · Cited by 256
Drug delivery to the retina: challenges and opportunities
Duvvuri, S., Majumdar, S., & Mitra, A. K. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.1.45 · Cited by 249
Chitosan-Alginate Blended Nanoparticles as Carriers for the Transmucosal Delivery of Macromolecules
Goycoolea, F. M., Lollo, G., Remuñán-López, C., Quaglia, F., & Alonso, M. J. (2009) · Biomacromolecules · doi:10.1021/bm9001377 · Cited by 238
Self-citationDe Campos, A. M., Sánchez, A., Gref, R., Calvo, P., & Alonso, M. J. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00178-7 · Cited by 234
Self-citationCalvo, P., Remuñán-López, C., Vila-Jato, J. L., & Alonso, M. J. (1997) · Colloid & Polymer Science · doi:10.1007/s003960050050 · Cited by 227
Self-citationBioadhesion of hydrated chitosans: An in vitro and in vivo study
Henriksen, I. (1996) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04776-x · Cited by 226
Aggarwal, D., & Kaur, I. P. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.10.026 · Cited by 223
SADEGHI, A., DORKOOSH, F., AVADI, M., WEINHOLD, M., BAYAT, A., DELIE, F., GURNY, R., LARIJANI, B., RAFIEETEHRANI, M., & JUNGINGER, H. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.03.004 · Cited by 223
Tiffany, J. M. (1991) · International Ophthalmology · doi:10.1007/bf00137947 · Cited by 216
Extracellular Glycosaminoglycans Modify Cellular Trafficking of Lipoplexes and Polyplexes
Ruponen, M., Rönkkö, S., Honkakoski, P., Pelkonen, J., Tammi, M., & Urtti, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011553200 · Cited by 206
Improved Ocular Bioavailability of Indomethacin by Novel Ocular Drug Carriers
Calvo, P., Alonso, M. J., Vila-Jato, J. L., & Robinson, J. R. (1996) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1996.tb03911.x · Cited by 206
Self-citationFormation of self-organized nanoparticles by lecithin/chitosan ionic interaction
Sonvico, F., Cagnani, A., Rossi, A., Motta, S., Di Bari, M. T., Cavatorta, F., Alonso, M. J., Deriu, A., & Colombo, P. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.06.036 · Cited by 202
Self-citationHosoya, K.-I., Lee, V. H. L., & Kim, K.-J. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.12.007 · Cited by 194
de la Fuente, M., Seijo, B., & Alonso, M. J. (2008) · Gene Therapy · doi:10.1038/gt.2008.16 · Cited by 194
Self-citationParacellular permeability of corneal and conjunctival epithelia.
Huang, A., Tseng, S. C. G., & Kenyon, K. R. (1989) · PubMed · Cited by 190
Vitreous: A Barrier to Nonviral Ocular Gene Therapy
Peeters, L., Sanders, N. N., Braeckmans, K., Boussery, K., Van de Voorde, J., De Smedt, S. C., & Demeester, J. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0165 · Cited by 189
Sustained Ocular Drug Delivery from a Temperature and pH Triggered Novel In Situ Gel System
Gupta, H., Jain, S., Mathur, R., Mishra, P., Mishra, A. K., & Velpandian, T. (2007) · Drug Delivery · doi:10.1080/10717540701606426 · Cited by 187
Effectiveness of sodium hyaluronate eyedrops in the treatment of dry eye
Johnson, M. E., Murphy, P. J., & Boulton, M. (2005) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-005-0028-1 · Cited by 172
Cordeiro, M. F., Mead, A., Ali, R. R., Alexander, R. A., Murray, S., Chen, C., York-Defalco, C., Dean, N. M., Schultz, G. S., & Khaw, P. T. (2003) · Gene Therapy · doi:10.1038/sj.gt.3301865 · Cited by 171
Biological barriers to cellular delivery of lipid-based DNA carriers
Bally, M. B., Harvie, P., Wong, F. M. P., Kong, S., Wasan, E. K., & Reimer, D. L. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00034-4 · Cited by 170
The potential of lipid emulsion for ocular delivery of lipophilic drugs
Shunmugaperumal, T., & Benita, S. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.033 · Cited by 167
Grenha, A., Remuñán-López, C., Carvalho, E. L. S., & Seijo, B. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.10.017 · Cited by 166
Self-citationLosa, C., Marchal-Heussler, L., Orallo, F., Jato, J. L. V., & Alonso, M. J. (1993) · Pharmaceutical Research · doi:10.1023/a:1018977130559 · Cited by 163
Self-citationChen, H. H., Ho, Y., Jiang, X., Mao, H., Wang, T., & Leong, K. W. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300392 · Cited by 155
Colloidal Carriers for Ophthalmic Drug Delivery
Mainardes, R. M., Urban, M. C. C., Cinto, P. O., Khalil, N. M., Chaud, M. V., Evangelista, R. C., & Gremião, M. P. D. (2005) · Current Drug Targets · doi:10.2174/1389450053765914 · Cited by 155
Treatment of diseases of the eye with mucoadhesive delivery systems
Greaves, J. L., & WILSON, C. G. (1993) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(93)90016-w · Cited by 153
Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA
Fattal, E., & Bochot, A. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.020 · Cited by 152
Extracellular and intracellular barriers in non-viral gene delivery
Ruponen, M. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.08.004 · Cited by 151
Liposome ocular delivery systems
Meisner, D., & Mezei, M. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00016-z · Cited by 150
Ito, T., Iida‐Tanaka, N., Niidome, T., Kawano, T., Kubo, K., Yoshikawa, K., Sato, T., Yang, Z., & Koyama, Y. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.03.013 · Cited by 150
Teijeiro‐Osorio, D., Remuñán‐López, C., & Alonso, M. J. (2008) · Biomacromolecules · doi:10.1021/bm800975j · Cited by 141
Self-citationChemically-Modified HA for Therapy and Regenerative Medicine
Prestwich, G. D., & Kuo, J.-W. (2008) · Current Pharmaceutical Biotechnology · doi:10.2174/138920108785161523 · Cited by 141
Activated polyamidoamine dendrimers, a non-viral vector for gene transfer to the corneal endothelium
Hudde, T., Rayner, S. A., Comer, R. M., Weber, M., Isaacs, J. D., Waldmann, H., Larkin, F., & George, A. J. T. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300886 · Cited by 140
Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B
Khatri, K., Goyal, A. K., Gupta, P. N., Mishra, N., & Vyas, S. P. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.11.027 · Cited by 140
Vitreous Is a Barrier in Nonviral Gene Transfer by Cationic Lipids and Polymers
Pitkänen, L., Ruponen, M., Nieminen, J., & Urtti, A. (2003) · Pharmaceutical Research · doi:10.1023/a:1023238530504 · Cited by 134
A new drug nanocarrier consisting of chitosan and hydoxypropylcyclodextrin
Maestrelli, F., García-Fuentes, M., Mura, P., & Alonso, M. J. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.12.006 · Cited by 133
Self-citationAlginate microsphere-collagen composite hydrogel for ocular drug delivery and implantation
Liu, W., Griffith, M., & Li, F. (2008) · Journal of Materials Science Materials in Medicine · doi:10.1007/s10856-008-3486-2 · Cited by 132
Emulsification and Stabilization Mechanisms of O/W Emulsions in the Presence of Chitosan
Payet, L., & Terentjev, E. M. (2008) · Langmuir · doi:10.1021/la8019217 · Cited by 129
Colo, G. D. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.12.018 · Cited by 127
Yuan, X., Yuan, Y.-B., Jiang, W., Liu, J., Tian, E.-J., Shun, H.-M., Huang, D., Yuan, X.-Y., Li, H., & Sheng, J. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.07.045 · Cited by 125
Bivas‐Benita, M., Laloup, M., Versteyhe, S., Dewit, J., Braekeleer, J. D., Jongert, E., & Borchard, G. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00377-6 · Cited by 123
Role of Metabolism in Ocular Drug Delivery
Duvvuri, S., Majumdar, S., & Mitra, A. K. (2004) · Current Drug Metabolism · doi:10.2174/1389200043335342 · Cited by 122
Qu, X., Khutoryanskiy, V. V., Stewart, A., Rahman, S., Papahadjopoulos‐Sternberg, B., Dufès, C., McCarthy, D., WILSON, C. G., Lyons, R. T., Carter, K. C., et al. (2006) · Biomacromolecules · doi:10.1021/bm0604000 · Cited by 121
Disposition of timolol and inulin in the rabbit eye following corneal versus non-corneal absorption
Ahmed, I. I. K., & Patton, T. F. (1987) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(87)90092-5 · Cited by 119
Barbault-Foucher, S., Gref, R., Russo, P., Guechot, J., & Bochot, A. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00207-9 · Cited by 118
Rheological characteristics of semi‐dilute chitosan solutions
Mucha, M. (1997) · Macromolecular Chemistry and Physics · doi:10.1002/macp.1997.021980220 · Cited by 116
Gene transfer with liposomes to the intraocular tissues by different routes of administration.
Masuda, I., Matsuo, T., Yasuda, T., & Matsuo, N. (1996) · PubMed · Cited by 115
Ocular Drug Delivery: Nanomedicine Applications
Vandervoort, J., & Ludwig, A. (2007) · Nanomedicine · doi:10.2217/17435889.2.1.11 · Cited by 114
Wang, W., & Xu, D. (1994) · International Journal of Biological Macromolecules · doi:10.1016/0141-8130(94)90042-6 · Cited by 113
Cell‐surface glycosaminoglycans inhibit cation‐mediated gene transfer
Ruponen, M., Honkakoski, P., Tammi, M., & Urtti, A. O. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.522 · Cited by 112
Collis, L., Hall, C. L., Lange, L., Ziebell, M. R., Prestwich, R. J. D., & Turley, E. A. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01505-1 · Cited by 112
Ocular Nanoparticle Toxicity and Transfection of the Retina and Retinal Pigment Epithelium
Prow, T. W., Bhutto, I., Kim, S. Y., Grebe, R., Merges, C., McLeod, D. S., Uno, K., Mennon, M., Rodriguez, L., Leong, K., et al. (2008) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.06.003 · Cited by 111
The cellular delivery of antisense oligonucleotides and ribozymes
Hughes, M. D., Hussain, M., Nawaz, Q., Sayyed, P. Z., & Akhtar, S. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(00)00326-3 · Cited by 111
Yuan, X.-B., Li, H., & Yuan, Y.-B. (2006) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2006.01.020 · Cited by 110
Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro
Teijeiro‐Osorio, D., Remuñán‐López, C., & Alonso, M. J. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.020 · Cited by 110
Self-citationIntracellular trafficking and transgene expression of viral and non-viral gene vectors
Kamiya, H., Tsuchiya, H., Yamazaki, J., & Harashima, H. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00216-2 · Cited by 110
Polyester Nanocapsules as New Topical Ocular Delivery Systems for Cyclosporin A
Calvo, P., Sánchez, A., Martínez, J., López, M. I., Calonge, M., Jimeno, J. C. P., & Alonso, M. J. (1996) · Pharmaceutical Research · doi:10.1023/a:1016015803611 · Cited by 108
Self-citationChitosan nanoparticles for drug delivery to the eye
Paolicelli, P., de la Fuente, M., Sánchez, A., Seijo, B., & Alonso, M. J. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902762818 · Cited by 108
Self-citationMajumdar, S., Hippalgaonkar, K., & Repka, M. A. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.08.017 · Cited by 107
Losa, C., Calvo, P., Castro, E., Vila-Jato, J. L., & Alonso, M. J. (1991) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1991.tb03534.x · Cited by 102
Self-citationHyaluronic acid and replacement of vitreous and aqueous humor.
Balazs, E. A., Freeman, M. I., Klöti, R., et al. (1972) · PubMed · Cited by 100
Non-viral ocular gene therapy: Potential ocular therapeutic avenues
Bloquel, C., Bourges, J., Touchard, E., Berdugo, M., BenEzra, D., & Béhar‐Cohen, F. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.07.023 · Cited by 93
Nanoparticles as Protein and Gene Carriers to Mucosal Surfaces
de la Fuente, M., Csaba, N., García-Fuentes, M., & Alonso, M. J. (2008) · Nanomedicine · doi:10.2217/17435889.3.6.845 · Cited by 93
Self-citationExogenous hyaluronidases and degradation of hyaluronic acid in the rabbit eye.
Knepper, P. A., Farbman, A. I., & Telser, A. (1984) · PubMed · Cited by 91
Hyaluronan and Human Endothelial Cell Behavior
Genasetti, A., Vigetti, D., Viola, M., Karousou, E., Moretto, P., Rizzi, M., Bartolini, B., Clerici, M., Pallotti, F., Luca, G. D., et al. (2008) · Connective Tissue Research · doi:10.1080/03008200802148462 · Cited by 87
Danielsen, S., Strand, S. P., Davies, C. D. L., & Stokke, B. T. (2004) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.10.011 · Cited by 84
Challenges and solutions in topical ocular drug-delivery systems
Ali, M., & Byrne, M. E. (2008) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.1.1.145 · Cited by 84
Chen, J., Yang, W., Li, G., Qian, J., Xue, J., Fu, S., & Lu, D. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i1.112 · Cited by 84
Jumaa, M. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00086-1 · Cited by 83
Polymeric materials for ophthalmic drug delivery: trends and perspectives
Barbu, E., Vereștiuc, L., Nevell, T. G., & Tsibouklis, J. (2006) · Journal of Materials Chemistry · doi:10.1039/b605640g · Cited by 82
Influence of Emulsion Droplet Surface Charge on Indomethacin Ocular Tissue Distribution
Klang, S. H., Abdulrazik, M., & Benita, S. (2000) · Pharmaceutical Development and Technology · doi:10.1081/pdt-100102035 · Cited by 80
Hornof, M., de la Fuente, M., Hallikainen, M., Tammi, R., & Urtti, A. O. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1125 · Cited by 78
Kompella, U. B., Sundaram, S., Raghava, S., & Escobar, E. R. (2006) · PubMed · Cited by 77
Hyaluronan and CD44 in the Human Cornea and Limbal Conjunctiva
Lerner, L. E., Schwartz, D. M., Hwang, D. G., et al. (1998) · Experimental Eye Research · doi:10.1006/exer.1998.0567 · Cited by 74
Recent developments in ocular gene therapy
Borrás, T. (2003) · Experimental Eye Research · doi:10.1016/s0014-4835(03)00030-7 · Cited by 74
Expression of adhesion molecule CD44 on human corneas
Zhu, S., Nölle, B., & Duncker, G. I. W. (1997) · British Journal of Ophthalmology · doi:10.1136/bjo.81.1.80 · Cited by 73
Mucoadhesive microparticles engineered for ophthalmic drug delivery
Choy, Y. B., Park, J., & Prausnitz, M. R. (2007) · Journal of Physics and Chemistry of Solids · doi:10.1016/j.jpcs.2007.10.043 · Cited by 72
Klang, S. H., Frucht‐Pery, J., Hoffman, A., et al. (1994) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1994.tb03254.x · Cited by 68
Csaba, N., Köping‐Höggård, M., Fernández-Megía, E., et al. (2009) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2009.1017 · Cited by 67
Delivery of Antisense Oligonucleotide to the Cornea by Iontophoresis
Berdugo, M., Valamanesh, F., Andrieu‐Soler, C., Klein, C., BenEzra, D., Courtois, Y., & Béhar‐Cohen, F. (2003) · Antisense and Nucleic Acid Drug Development · doi:10.1089/108729003321629647 · Cited by 67
Regnström, K. J., Ragnarsson, E., Fryknäs, M., Köping‐Höggård, M., & Artursson, P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-9563-7 · Cited by 64
Ocular gene therapy: quo vadis?
Hauswirth, W. W., & Beaufrère, L. (2000) · PubMed · Cited by 54
Effects of N-trimethylchitosan on transcellular and paracellular transcorneal drug transport
Zambito, Y., Zaino, C., & Colo, G. D. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.01.004 · Cited by 53
Hyaluronan-Induced Stimulation of Corneal Wound Healing is a Pure Pharmacological Effect
Camillieri, G., Bucolo, C., Rossi, S., & Drago, F. (2004) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2004.20.548 · Cited by 49
Gene delivery to the retina: focus on non-viral approaches
Naik, R. J., Mukhopadhyay, A., & Ganguli, M. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.09.012 · Cited by 48
Positively charged submicron emulsions — a new type of colloidal drug carrier
Elbaz, E., Zeevi, A., Klang, S. H., et al. (1993) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(93)90237-a · Cited by 48
Efficiency and Toxicity of Liposome-mediated Gene Transfer to Corneal Endothelial Cells
Pleyer, U., Groth, D., Hinz, B., Keil, O., Bertelmann, E., Rieck, P. W., & Reszka, R. C. (2001) · Experimental Eye Research · doi:10.1006/exer.2001.1005 · Cited by 45
When nanotechnology meets the ocular surface
Bucolo, C., Maltese, A., & Drago, F. (2008) · Expert Review of Ophthalmology · doi:10.1586/17469899.3.3.325 · Cited by 42
Tear lipocalin is the major endonuclease in tears.
Yusifov, T., Abduragimov, A. R., Narsinh, K. F., Gasymov, O. K., & Glasgow, B. J. (2008) · Europe PMC (PubMed Central) · Cited by 39
Turan, K., & Nagata, K. (2006) · Pharmaceutical Development and Technology · doi:10.1080/10837450600940873 · Cited by 38
Nanotechnology for ocular therapeutics and tissue repair
Raju, H. B., & Goldberg, J. L. (2008) · Expert Review of Ophthalmology · doi:10.1586/17469899.3.4.431 · Cited by 35
Eliaz, R. E., Nir, S., & Szoka, F. C. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)87002-2 · Cited by 34
Delivery of antibiotics to the eye using a positively charged polysaccharide as vehicle
Felt, O., Gurny, R., & Baeyens, V. (2001) · AAPS PharmSci · doi:10.1208/ps030434 · Cited by 34
Barriers in Ocular Drug Delivery
Gunda, S., Hariharan, S., Mandava, N. K., & Mitra, A. K. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-375-2_21 · Cited by 33
The Conjunctival Barrier in Ocular Drug Delivery
Gukasyan, H. J., Kim, K., & Lee, V. H. L. (2007) · Springer eBooks · doi:10.1007/978-0-387-74901-3_13 · Cited by 26
Losa, C., Alonso, M. J., VILA, J. L., Orallo, F., MARTINEZ, J., Saavedra, J. A., & Jimeno, J. C. P. (1992) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1992.8.191 · Cited by 25
Self-citationMeasurement and Prediction of Transient Transport across Sclera for Drug Delivery to the Eye
Prausnitz, M. R., Edwards, A., Noonan, J. S., Rudnick, D. E., Edelhauser, H. F., & Geroski, D. H. (1998) · Industrial & Engineering Chemistry Research · doi:10.1021/ie9800952 · Cited by 21
Receptors for Hyaluronan on Corneal Endothelial Cells
Forsberg, N., von Malmborg, A., Madsen, K., Rolfsen, W. N. A., & Gustafson, S. (1994) · Experimental Eye Research · doi:10.1006/exer.1994.1154 · Cited by 17
Gene therapy in immune-mediated diseases of the eye
Pleyer, U. (2003) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(02)00046-0 · Cited by 16
Gene therapy for ocular neovascularization: a cure in sight
Reich, S. J., & Bennett, J. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00043-1 · Cited by 15
Chitosan-polysaccharide blended nanoparticles for controlled drug delivery
ALONSO, J. M., Goycoolea, F. M., & Higuera‐Ciapara, I. (2008) · Elsevier eBooks · doi:10.1533/9781845694814.5.644 · Cited by 14
Cited by
Chitosan—A versatile semi-synthetic polymer in biomedical applications
Dash, M., Chiellini, F., Ottenbrite, R. M., & Chiellini, E. (2011) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.02.001 · Cited by 2,903
Sapsford, K. E., Algar, W. R., Berti, L., Gemmill, K. B., Casey, B. J., Oh, E., Stewart, M. H., & Medintz, I. L. (2013) · Chemical Reviews · doi:10.1021/cr300143v · Cited by 1,423
Ahmed, T., & Aljaeid, B. (2016) · Drug Design, Development and Therapy · doi:10.2147/dddt.s99651 · Cited by 705
Advances in Mucoadhesion and Mucoadhesive Polymers
Khutoryanskiy, V. V. (2011) · Macromolecular Bioscience · doi:10.1002/mabi.201000388 · Cited by 655
Thin films as an emerging platform for drug delivery
Karki, S., Kim, H., Na, S.-J., Shin, D., Jo, K., & Lee, J. (2016) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2016.05.004 · Cited by 543
Metadata
- Authors
- de la Fuente, M., Raviña, M., Paolicelli, P., Sanchez, A., Seijo, B., & Alonso, M. J.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2010-01
- Volume
- 62
- Issue
- 1
- Pages
- 100-117
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2071567196
- Cited by
- 354
- References
- 175
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.